Cargando…
Hepatitis B Treatment: What We Know Now and What Remains to Be Researched
Chronic hepatitis B virus (HBV) infection remains a major global health burden. Currently, two types of treatment, interferons (IFNs) and nucleos(t)ide analogues (NAs), have been approved. These treatments are effective in suppressing HBV replication and in decreasing the risk of developing cirrhosi...
Autor principal: | Suk‐Fong Lok, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312657/ https://www.ncbi.nlm.nih.gov/pubmed/30619990 http://dx.doi.org/10.1002/hep4.1281 |
Ejemplares similares
-
COVID-19 Imaging: What We Know Now and What Remains Unknown
por: Kanne, Jeffrey P., et al.
Publicado: (2021) -
Human metapneumovirus - what we know now
por: Shafagati, Nazly, et al.
Publicado: (2018) -
Primary Hepatic Neuroendocrine Tumor: What Do We Know Now?
por: Quartey, Benjamin
Publicado: (2011) -
Halogenation in Fungi: What Do We Know and What Remains to Be Discovered?
por: Cochereau, Bastien, et al.
Publicado: (2022) -
We know CBT-I works, now what?
por: Muench, Alexandria, et al.
Publicado: (2022)